indomethacin has been researched along with Sicca Syndrome in 11 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NK lymphocytosis is rarely associated with autoimmune disease, but the combination of indomethacin and steroid therapy may have a favorable effect for such patients." | 5.34 | Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. ( Fujii, T; Fujita, Y; Mimori, T; Takeda, N; Tanaka, M, 2007) |
| "NK lymphocytosis is rarely associated with autoimmune disease, but the combination of indomethacin and steroid therapy may have a favorable effect for such patients." | 1.34 | Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. ( Fujii, T; Fujita, Y; Mimori, T; Takeda, N; Tanaka, M, 2007) |
| "In most cases, Sweet's syndrome may occur in the absence of other diseases." | 1.34 | [Sweet's syndrome: a propos of 8 cases]. ( Ayed, MB; Benmously, R; Debbiche, A; Fenniche, S; Marrek, H; Mokhtar, I; Souissi, A; Zarrouk, M, 2007) |
| "Sjogren's syndrome and ankylosing spondylitis can occur either alone or in conjunction with other disorders." | 1.33 | Coexisting ankylosing spondylitis and Sjogren's syndrome: a case report. ( Cakirbay, H; Capkin, E; Guler, M; Karkucak, M; Topbas, M; Tosun, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aragona, P | 1 |
| Stilo, A | 1 |
| Ferreri, F | 1 |
| Mobrici, M | 1 |
| Tosun, M | 1 |
| Karkucak, M | 1 |
| Capkin, E | 1 |
| Cakirbay, H | 1 |
| Guler, M | 1 |
| Topbas, M | 1 |
| Roca, V | 1 |
| Larocca, L | 1 |
| Calafat, M | 1 |
| Aisemberg, J | 1 |
| Meiss, R | 1 |
| Franchi, AM | 1 |
| Leirós, CP | 1 |
| Fujita, Y | 1 |
| Fujii, T | 1 |
| Takeda, N | 1 |
| Tanaka, M | 1 |
| Mimori, T | 1 |
| Souissi, A | 1 |
| Benmously, R | 1 |
| Fenniche, S | 1 |
| Zarrouk, M | 1 |
| Marrek, H | 1 |
| Debbiche, A | 1 |
| Ayed, MB | 1 |
| Mokhtar, I | 1 |
| Miyasaka, N | 2 |
| Seaman, W | 1 |
| Bakshi, A | 1 |
| Sauvezie, B | 1 |
| Strand, V | 1 |
| Pope, R | 1 |
| Talal, N | 1 |
| McKendry, RJ | 1 |
| Virella, G | 1 |
| Espinoza, A | 1 |
| Patrick, H | 1 |
| Colwell, JA | 1 |
| Pedersen, BK | 1 |
| Oxholm, P | 1 |
| Manthorpe, R | 1 |
| Andersen, V | 1 |
| Murota, N | 1 |
| Yamaoka, K | 1 |
| Sato, K | 1 |
| Yamada, T | 1 |
| Nishido, T | 1 |
| Okuda, M | 1 |
| Henkind, P | 1 |
| Gold, DH | 1 |
1 review available for indomethacin and Sicca Syndrome
| Article | Year |
|---|---|
Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
Topics: Adrenal Cortex Hormones; Arteritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Chloroquine; Conjunc | 1973 |
1 trial available for indomethacin and Sicca Syndrome
| Article | Year |
|---|---|
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dry Eye Syndromes; Epithel | 2005 |
9 other studies available for indomethacin and Sicca Syndrome
| Article | Year |
|---|---|
Coexisting ankylosing spondylitis and Sjogren's syndrome: a case report.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non | 2005 |
Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice.
Topics: Animals; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Dinoprostone; Enzyme Activation; Fema | 2006 |
Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Female; Glucocorticoids; Humans; In | 2007 |
[Sweet's syndrome: a propos of 8 cases].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anti-Inflammatory Agents, N | 2007 |
Natural killing activity in Sjögren's syndrome. An analysis of defective mechanisms.
Topics: Adult; Aged; Antigen-Antibody Complex; Catalase; Female; Humans; Hydrogen Peroxide; Indomethacin; Ki | 1983 |
Treatment of Sjogren's syndrome with essential fatty acids, pyridoxine and vitamin C.
Topics: Ascorbic Acid; Aspartate Aminotransferases; Aspirin; Fatty Acids, Essential; Female; Humans; Indomet | 1982 |
Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes.
Topics: Adenosine Triphosphate; Antigen-Antibody Complex; Blood Coagulation Factors; Cell Membrane; Glucuron | 1982 |
Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Topics: Humans; Indomethacin; Killer Cells, Natural; Sjogren's Syndrome; Stimulation, Chemical | 1986 |
Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
Topics: Adult; Female; Humans; Indomethacin; Interleukin-1; Interleukin-2; Lung; Macrophages; Middle Aged; P | 1986 |